Romanian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

angioedema/obezitate

Linkul este salvat în clipboard
ArticoleStudii cliniceBrevete
Pagină 1 din 29 rezultate

Obesity in children. Environment or genes? New treatment for hereditary angioedema.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare

COVID-19 - associated urticaria with angioedema in a morbidly obese male successfully treated with glucocorticoids

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
UNASSIGNED Icatibant is a bradykinin B2-receptor antagonist used for the treatment of hereditary angioedema attacks resulting from C1-inhibitor deficiency. Treatment is not adjusted by body weight however the impact of body mass index (BMI) on the effectiveness of icatibant is not documented in the

Snoring-Induced Vibratory Angioedema.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
BACKGROUND Vibratory angioedema (VA) is a rare physical urticaria, with symptoms of itching and swelling of the skin or mucosa when it is exposed to vibration. Avoidance of vibration is the best way to manage this condition. This case report will assist physicians to diagnose this rare condition.

Cystic ovaries in women affected with hereditary angioedema.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
Polycystic ovary (PCO) syndrome is biochemically characterized by abnormal gonadotropin secretion and polycystic ovaries associated with increase in size and functional activity of stromal tissue; multifollicular ovaries (MFO) are defined by the presence of multiple cysts with no increase in stromal

Anabolic androgen use in the management of hereditary angioedema: Not so cheap after all.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
Hereditary angioedema due to C1 inhibitor deficiency (HAE) is a rare, life-threatening disease that imposes a significant burden on affected patients. 17α-alkylated androgens (anabolic androgens) decrease attack frequency and severity but carry the risk of potentially serious dose-related adverse

Hereditary angioneurotic oedema: current management in pregnancy.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
A 20-year-old primiparous woman, with a history of type 1 hereditary angioneurotic oedema, presented for induction of labour. She was hirsute, obese and presented technical difficulties for both general and epidural/spinal anaesthesia. Her management included prophylactic C1 esterase inhibitors and
BACKGROUND Despite the worldwide obesity epidemic, there have been very few studies investigating the influence of body weight on treatment dosing and outcomes in patients with hereditary angioedema (HAE). OBJECTIVE The purpose of this analysis was to determine whether the standard weight-based

Ecallantide for treatment of acute hereditary angioedema attacks: analysis of efficacy by patient characteristics.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
Hereditary angioedema (HAE) is characterized by episodic attacks of edema. HAE is caused by low levels of the protein C1 esterase inhibitor, which inhibits plasma kallikrein, the enzyme responsible for converting high-molecular-weight kininogen to bradykinin. Unregulated production of bradykinin

Airway obstruction due to late-onset angioneurotic edema from angiotensin-converting enzyme inhibition.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
OBJECTIVE Angioneurotic edema is a well-documented complication of angiotensin-converting enzyme inhibitors (ACEI). We report a case of acute airway obstruction from a late-onset, probable ACEI-related angioneurotic edema and its subsequent management. METHODS A 48-yr-old obese man presented for

Life-threatening angioedema induced by angiotensin-converting enzyme inhibitors: characteristics and risk factors.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
BACKGROUND Angioedema induced by angiotensin-converting enzyme inhibitors (ACEIs) is a well-known phenomenon and roughly accounts for one-third of angioedema cases presenting to the emergency departments. This study aimed to characterize the patients with severe reactions that required

Case of severe bullous erythema including intertrigo-like eruptions with angioedema induced by pegylated liposomal doxorubicin.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
Pegylated liposomal doxorubicin (PLD) is an anthracycline anticancer agent used in ovarian cancer and a form of doxorubicin enclosed in pegylated liposomes. There are only a few reports on intertrigo-like eruptions caused by PLD. We describe the first case of severe bullous erythema, including

Angiotensin-converting enzyme inhibitor-induced small-bowel angioedema: clinical and imaging findings in 20 patients.

Numai utilizatorii înregistrați pot traduce articole
Log In / Înregistrare
OBJECTIVE The purpose of this article is to retrospectively review the radiologic and clinical findings in patients with angiotensin-converting enzyme inhibitor (ACEI)-induced small-bowel angioedema, with an emphasis on CT findings. METHODS Imaging findings, with an emphasis on CT, and clinical
Despite existing therapy, successful control of hypertension in the United States is estimated at less than 50%. In blacks, hypertension occurs earlier, is more severe, controlled less often and has a higher morbidity and mortality than in whites. Blacks are also less responsive to
Alăturați-vă paginii
noastre de facebook

Cea mai completă bază de date cu plante medicinale susținută de știință

  • Funcționează în 55 de limbi
  • Cure pe bază de plante susținute de știință
  • Recunoașterea ierburilor după imagine
  • Harta GPS interactivă - etichetați ierburile în locație (în curând)
  • Citiți publicațiile științifice legate de căutarea dvs.
  • Căutați plante medicinale după efectele lor
  • Organizați-vă interesele și rămâneți la curent cu noutățile de cercetare, studiile clinice și brevetele

Tastați un simptom sau o boală și citiți despre plante care ar putea ajuta, tastați o plantă și vedeți boli și simptome împotriva cărora este folosit.
* Toate informațiile se bazează pe cercetări științifice publicate

Google Play badgeApp Store badge